Kathleen Polson

498 total citations
9 papers, 367 citations indexed

About

Kathleen Polson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Kathleen Polson has authored 9 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Gastroenterology. Recurrent topics in Kathleen Polson's work include Sarcoma Diagnosis and Treatment (4 papers), Vascular Tumors and Angiosarcomas (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Kathleen Polson is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Vascular Tumors and Angiosarcomas (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Kathleen Polson collaborates with scholars based in United States, South Korea and Germany. Kathleen Polson's co-authors include Suzanne George, Jeffrey A. Morgan, George D. Demetri, Andrew J. Wagner, Nathaniel S. Treister, F. Stephen Hodi, Constance M. Barysauskas, Scott J. Rodig, Geoffrey I. Shapiro and Priscilla Merriam and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Oncologist.

In The Last Decade

Kathleen Polson

9 papers receiving 357 citations

Peers

Kathleen Polson

PRM

ONCOL

IMMUN

PFM

MB

Ayşe Durnalı Türkiye

A. Le Cesne France

Joanna Huszno Poland

Michael J. Nathenson United States

Nasim Ali United Kingdom

Kimitaka Miyajima Japan

Satoru Yasukawa Japan

Takashi Ichimura Japan

Emine Kılıç Bağır Türkiye

P. Chalabreysse France

Ayşe Durnalı Türkiye

Kathleen Polson

157 ×0.6

PRM

173 ×0.7

ONCOL

9 ×0.2

IMMUN

63 ×1.2

PFM

55 ×1.3

MB

Citations per year, relative to Kathleen Polson Kathleen Polson (= 1×) peers Ayşe Durnalı

Countries citing papers authored by Kathleen Polson

Since Specialization

Citations

This map shows the geographic impact of Kathleen Polson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Polson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Polson more than expected).

Fields of papers citing papers by Kathleen Polson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Polson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Polson. The network helps show where Kathleen Polson may publish in the future.

Co-authorship network of co-authors of Kathleen Polson

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Polson. A scholar is included among the top collaborators of Kathleen Polson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Polson. Kathleen Polson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Polson, Kathleen, et al.. (2023). Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team. Orphanet Journal of Rare Diseases. 18(1). 313–313. 1 indexed citations

2.

Polson, Kathleen, et al.. (2023). Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib. Journal of the Advanced Practitioner in Oncology. 14(4). 317–328. 1 indexed citations

3.

Polson, Kathleen, Robin L. Jones, Yoon‐Koo Kang, et al.. (2020). Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors. The Oncologist. 26(4). e622–e631. 25 indexed citations

4.

Ben‐Ami, Eytan, Constance M. Barysauskas, Sarah Solomon, et al.. (2017). Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study. Cancer. 123(17). 3285–3290. 163 indexed citations

5.

George, Suzanne, Constance M. Barysauskas, Sarah Solomon, et al.. (2016). Phase 2 study of nivolumab in metastatic leiomyosarcoma of the uterus.. Journal of Clinical Oncology. 34(15_suppl). 11007–11007. 13 indexed citations

6.

Polson, Kathleen, et al.. (2011). Managing Stomatitis in Patients Treated With Mammalian Target of Rapamycin Inhibitors. Clinical journal of oncology nursing. 15(5). E83–E89. 57 indexed citations

7.

Theman, Todd A., Tristan L. Hartzell, Indranil Sinha, et al.. (2009). Recognition of a New Chemotherapeutic Vesicant: Trabectedin (Ecteinascidin-743) Extravasation With Skin and Soft Tissue Damage. Journal of Clinical Oncology. 27(33). e198–e200. 30 indexed citations

8.

Dileo, Palma, Jeffrey A. Morgan, David Zahrieh, et al.. (2007). Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas. Cancer. 109(9). 1863–1869. 56 indexed citations

9.

Demetri, George D., Suzanne George, Jeffrey A. Morgan, et al.. (2007). Inhibition of the Heat Shock Protein 90 (Hsp90) chaperone with the novel agent IPI-504 to overcome resistance to tyrosine kinase inhibitors (TKIs) in metastatic GIST: Updated results of a phase I trial. Journal of Clinical Oncology. 25(18_suppl). 10024–10024. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact